Mechanism of hepatoprotective action of bile salts in liver disease (Q33591454)

28 July 2017

1 reference

title

Mechanism of hepatoprotective action of bile salts in liver disease (English)

1 reference

28 July 2017

Stiehl A

1

1 reference

28 July 2017

Benz C

series ordinal

2

1 reference

28 July 2017

Sauer P

series ordinal

3

1 reference

28 July 2017

publication date

1 March 1999

1 reference

Gastroenterology Clinics of North America

28 July 2017

published in

1 reference

28 July 2017

volume

28

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

195-209, viii

1 reference

Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Drug-Induced Cholestasis in the Perfused Rat Liver and Its Reversal by Tauroursodeoxycholate: An Ultrastructural Study

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejection

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effect of taurochenodeoxycholate or tauroursodeoxycholate upon biliary output of phospholipids and plasma-membrane enzymes, and the extent of cell damage, in isolated perfused rat livers.

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease?

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effect of S-adenosylmethionine versus tauroursodeoxycholic acid on bile acid-induced apoptosis and cytolysis in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Cytokines in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca mechanisms defective in cholestasis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-alpha production by monocytes

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Intravenous ursodeoxycholic acid reduces cholestasis in parenterally fed newborn piglets

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effect of ursodeoxycholic acid treatment on ileal absorption of bile acids in man as determined by the SeHCAT test

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Molecular aspects of membrane stabilization by ursodeoxycholate [see comment]

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Evidence of preservation injury to bile ducts by bile salts in the pig and its prevention by infusions of hydrophilic bile salts

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts.

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effects of bile acids and cholestasis on major histocompatibility complex class I in human and rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Regulation of the major histocompatibility complex class I mRNA expression by bile acids in cultured human hepatoma cells

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effects of ursodeoxycholic acid and chenodeoxycholic acid on major histocompatibility complex class I gene expression

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Ursodeoxycholic acid for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Improvement of Estradiol- 17β-D-Glucuronide-Induced Cholestasis by Sodium Tauroursodeoxycholate Therapy in Rats

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Tauro alpha-muricholate is as effective as tauro beta-muricholate and tauroursodeoxycholate in preventing taurochenodeoxycholate-induced liver damage in the rat

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Ursodeoxycholic acid improves the hepatic metabolism of essential fatty acids and retinol in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Ursodeoxycholic acid in primary biliary cirrhosis: no evidence for toxicity in the stages I to III.

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Ursodeoxycholic acid therapy in the treatment of biliary atresia

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Inhibition of bile-salt-induced hepatocyte apoptosis by the antioxidant lazaroid U83836E

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Protective role of biliary cholesterol and phospholipid lamellae against bile acid-induced cell damage

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid-induced cholestasis in the rat

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effects of ursodeoxycholic acid (UDCA) on serum liver damage indices in patients with chronic active hepatitis. A double-blind controlled study

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Mitogen-activated protein kinases mediate the stimulation of bile acid secretion by tauroursodeoxycholate in rat liver

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Hepatic injury induced by bile salts: correlation between biochemical and morphological events

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Ursodeoxycholate increases cytosolic calcium concentration and activates CI− currents in a biliary cell line

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Ileal excretion of bile acids: Comparison with biliary bile composition and effect of ursodeoxycholic acid treatment

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effect of ursodeoxycholic acid on biliary bile acid and bile lipid composition in gallstone patients

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effect of tauro-alpha-muricholate and tauro-beta-muricholate on oestradiol-17 beta-glucuronide-induced cholestasis in rats

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene.

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

Immunomodulatory effects of ursodeoxycholic acid on immune responses

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(05)70050-9

7 January 2021

10.1016/S0889-8553(05)70050-9

Identifiers

DOI

1 reference

28 July 2017

1 reference